World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
15944
World Ranking
20020
National Ranking
9971

Overview

Glen R. Hanson is affiliated with the University of Utah in the United States and conducts research primarily in the field of neuroscience. Their work encompasses several subfields including cellular and molecular neuroscience, toxicology, molecular biology, experimental and cognitive psychology, and agronomy and crop science.

The scientist's research focuses on topics related to neurotransmitter receptor influence on behavior, forensic toxicology and drug analysis, neuroscience and neuropharmacology research, nicotinic acetylcholine receptors study, receptor mechanisms and signaling, sleep and related disorders, and reproductive physiology in livestock.

Recent publications authored or co-authored by Glen R. Hanson include:

  • 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters, 2020, Journal of Pharmacology and Experimental Therapeutics
  • Methcathinone decreases dopamine transporter function: Role of protein kinase C, 2021, Journal of Neurochemistry
  • Methcathinone Rapidly Decreases Dopamine Transporter Function: Role of Calcium and Protein Kinase C, 2020, The FASEB Journal
  • 0327 Seasonal and Contextual Effects on Habitual Sleep Patterns in MoTrPAC's Children and Adolescents, 2025, SLEEP
  • 0317 Measurement Consistency of Habitual Sleep Patterns of Children and Adolescents in the MoTrPAC Study, 2025, SLEEP

Frequent co-authors collaborating with Hanson include:

  • Annette E. Fleckenstein
  • Charlotte P. Magee
  • Yasmeen H. Siripathane
  • Diana G. Wilkins
  • BaoMinh D. Le

Hanson's research has been published across various scientific venues with repeated contributions to the journal SLEEP. Other significant publication venues include the Journal of Pharmacology and Experimental Therapeutics, Journal of Neurochemistry, The FASEB Journal, and Journal of Animal Science.

Best Publications

  • New insights into the mechanism of action of amphetamines.

    Annette E. Fleckenstein;Trent J. Volz;Evan L. Riddle;James W. Gibb

  • The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

    Donna M. Stone;Danese C. Stahl;Glen R. Hanson;James W. Gibb

  • Role of dopamine in the neurotoxic effects of methamphetamine.

    C J Schmidt;J K Ritter;P K Sonsalla;G R Hanson

  • Bath salts and synthetic cathinones: An emerging designer drug phenomenon

    Christopher L. German;Annette E. Fleckenstein;Glen R. Hanson

  • 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

    Gregory C. Hadlock;Katy M. Webb;Lisa M. McFadden;Pei Wen Chu

  • Rapid and reversible effects of methamphetamine on dopamine transporters.

    Annette E. Fleckenstein;Ryan R. Metzger;Diana G. Wilkins;James W. Gibb

  • Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

    Annette E. Fleckenstein;James W. Gibb;Glen R. Hanson

  • Drugs and Society

    Glen R Hanson;Peter J Venturelli;Annette E Fleckenstein

  • Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.

    D M Stone;M Johnson;G R Hanson;J W Gibb

  • Mechanisms of methamphetamine-induced dopaminergic neurotoxicity

    Evan L. Riddle;Annette E. Fleckenstein;Glen R. Hanson

  • Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

    Donna M. Stone;K.M. Merchant;G.R. Hanson;J.W. Gibb

  • Methamphetamine rapidly decreases vesicular dopamine uptake.

    Jeffrey M. Brown;Glen R. Hanson;Annette E. Fleckenstein

  • Roles of D1 and D2 dopamine receptor subtypes in mediating the methamphetamine-induced changes in monoamine systems.

    P K Sonsalla;J W Gibb;G R Hanson

  • Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease

    Christopher L. German;Michelle G. Baladi;Lisa M. McFadden;Glen R. Hanson

  • Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment

    Karen Curtin;Karen Curtin;Annette E. Fleckenstein;Reid J. Robison;Reid J. Robison;Michael J. Crookston

  • Regulation of the Vesicular Monoamine Transporter-2: A Novel Mechanism for Cocaine and Other Psychostimulants

    Jeffrey M. Brown;Glen R. Hanson;Annette E. Fleckenstein

  • Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function

    Annette E Fleckenstein;Heather M Haughey;Ryan R Metzger;Jerry M Kokoshka

  • Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.

    D M Stone;G R Hanson;J W Gibb

  • Effects of cocaine on extrapyramidal and limbic dynorphin systems.

    P L Smiley;M Johnson;L Bush;J W Gibb

  • Methylphenidate Redistributes Vesicular Monoamine Transporter-2: Role of Dopamine Receptors

    Verónica Sandoval;Evan L. Riddle;Glen R. Hanson;Annette E. Fleckenstein

Frequent Co-Authors

Patricia K. Sonsalla
Patricia K. Sonsalla Rutgers, The State University of New Jersey
James K. Wamsley
James K. Wamsley IQVIA (United States)
Walter Lovenberg
Walter Lovenberg National Institutes of Health
Ray E. Hershberger
Ray E. Hershberger The Ohio State University
Michael R. Bristow
Michael R. Bristow University of Colorado Anschutz Medical Campus
Patrick L. Iversen
Patrick L. Iversen Oregon State University
Larry S. Barak
Larry S. Barak Duke University
Rick A. Bevins
Rick A. Bevins University of Nebraska–Lincoln
John W. Haycock
John W. Haycock Louisiana State University Health Sciences Center New Orleans
Raymond P. Kesner
Raymond P. Kesner University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in medicine doesn’t always mean pursuing a traditional MD. Many students choose alternative online degree programs that open doors to rewarding roles in healthcare. For registered nurses, adn to np bridge programs provide a streamlined path to becoming a nurse practitioner, enabling advanced practice and leadership opportunities.

Those interested in nutrition and preventive care might consider earning a best online food science degree, which can lead to careers in dietetics, wellness, and public health. For aspiring healthcare managers, cahme accredited online healthcare administration programs offer respected credentials that prepare graduates for leadership roles in hospitals and clinics.

Flexible pathways also exist for nurses seeking advancement. Some rn to bsn programs without clinicals allow busy professionals to earn their bachelor’s degrees 100% online, ideal for those balancing work and study. These diverse educational routes enable more people to make a meaningful impact in patient care and healthcare management.

Best Scientists Citing Glen R. Hanson

Trending Scientists